Company
Team
CORPORATE GOVERNANCE
Platforms
Glycovirology
Galectin-3
Diseases and Therapies
pipeline
ProLectin Pipeline
Degenerative Disease pipeline
Resources
IN THE NEWS
Articles
SCIENTIFIC PUBLICATIONS
investors
Company presentation
press releases
Research
financial
Contact US
$BIXT
Company
Platforms
Glycovirology
Diseases and Therapies Overview
Resources
Investors
Pipeline
contact us
NASH
Publications
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
go back